EU Health Policy Platform Calls for Proposals: 2021 Thematic Networks

European CommissionThe European Commission is inviting public health stakeholders to submit initiatives for anew cycle of Thematic Networks under the EU Health Policy Platform. The purpose of a Thematic Network is to produce a Joint Statement within a year, summarising the common position of a group of stakeholder organisations on one of the following selected public health areas:
  • Adaptation actions on climate change and health
  • Health inequalities with regard to ethnic minorities and racism
  • Improving public information on the health effects of air pollution
  • Integrative Oncology in patient-centred cancer care
  • The Pharmaceutical Strategy

The European Commission may also consider proposals from other policy areas if stakeholders from other fields of public health present sound reasons for doing so; or combinations of several policy areas mentioned above.

The Joint Statements shall advice the European Commission on its policy activities and shall encourage the stakeholder's community to join forces and carry out their own activities/initiatives in synergy with those carried out by the Commission and the Member States. For this reason, proposals addressed by Thematic Networks should be in line with the EU health policy agenda. Thematic networks are encouraged to make use of all the information made available to them to prepare Joint Statements that engage the commitment of the stakeholder community.

Joint Statements are not binding for the European Commission. They are owned by the organisation leading the Thematic Network. The work on the Joint Statements is the responsibility of the organisations involved in drafting it through the Health Policy Platform. Ideally, Joint Statements should commit the stakeholder's community to carry out work in the selected domains in synergy with the action taken by the European Commission informing about the relevant challenges, solutions and best practices.

To apply please:

  • Prepare a brief summary of your proposal (maximum 2 pages)
    • Include the scope of your future Joint Statement
    • Explain the relevance of your proposal for the selected area and the possible synergy with ongoing or planned EU actions on health in the European Union
    • State your objectives and how you will reach them
    • List your possible network and partners involved (you can include logos if you wish)
    • State the leading organisation clearly
    • Contact person and details
  • Send your proposal to the email address: This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Deadline: 7 June 2021

The European Commission will evaluate the proposals received by topic and select a maximum of 6. These 6 proposals will be presented in a poll in the Agora network (the main network of the EU Health Policy Platform), where all registered users of the Platform will be allowed to vote. The poll will be open during three weeks. We encourage stakeholders to register in advance in the EU Health Policy Platform to vote for their preferred Thematic Network, as last-minute registrations cannot be guaranteed.

The 3 proposals with the most votes in the EU Health Policy Platform poll will be considered as the final proposals for the 2021 Thematic Networkscycle, and will kick-off immediately after the poll, and at the latest in early September 2021.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...